Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic Profile of Terlipressin vs Octreotide in Cirrhosis
NCT04353193Phase 4Unknown
- Start
- Jun 2020
- Primary completion
- Feb 2022
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of terlipressin in Portal Hypertension (PH). Status: unknown.
02
Drugs
terlipressin
03
Conditions
Portal Hypertension (PH)
Beyond the preview
Go deeper on NCT04353193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04353193.